How It works, cost and more
Hum Neurobiol 6 : 19
Ohio to end GLP-1 drug weight loss coverage for state workers COLUMBUS, Ohio (WSYX) The Ohio Department of Administrative Services announced that coverage for GLP-1 drugs for weight loss, including Ozempic and Mounjaro, will end for state employees on July 1, 2025
Cag 10: A long-acting synthetic analogue of human amylin, engineered with fatty acid acylation to extend its half-life and enable sustained amylin receptor activation over a significantly longer duration than native amylin allows
The fact that there's a medically approved prescription for managing weight and staying healthier, in my lifetime, feels like relief, like redemption, like a gift, and not something to hide behind and once again be ridiculed for